Can anyone assist me regarding Suba
Itraconazole. Mayne financed Hedgepath
US5m then acquired 100% ownership of
huge potential product. In 2018 they
announced a phase 3 trial would commence
in 2019. After another bucket load of R and D
I just wonder how these trials are progressing.
It was along with Myring often talked up by
Richards. Anybody please ??
Can anyone assist me regarding SubaItraconazole. Mayne financed...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M | |||
| Open | High | Low | Value | Volume |
| $5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 810 | $5.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.15 | 2033 | 2 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |